As cancer immunotherapy continues to evolve, understanding the intricate dynamics of the tumor microenvironment (TME) has become a central focus for researchers. On September 1, 2026, Creative Biolabs will present a live webinar titled "Modeling T Cell Dysfunction in Tumor Microenvironments," featuring Dr. Greg M. Delgoffe, a professor of immunology at the University of Pittsburgh and director of the Tumor Microenvironment Center at the UPMC Hillman Cancer Center. The event aims to shed light on how metabolic stress within tumors drives immune suppression and T cell exhaustion, which are critical barriers to effective treatment.
The TME is a complex ecosystem where cancer cells, immune cells, and metabolic byproducts interact. As tumors progress, they create a hostile environment characterized by nutrient depletion and accumulation of immunosuppressive metabolites. These conditions impair T cell function, leading to immune evasion and reduced responses to standard immunotherapies. Traditional in vitro and in vivo models often fail to capture these nuanced interactions, limiting their predictive value for clinical outcomes. Dr. Delgoffe's presentation will focus on innovative approaches to model these metabolic challenges using advanced preclinical testing services and robust in vivo and in vitro systems. Such models enable researchers to replicate the metabolic stress conditions more accurately, providing valuable insights into immune suppression and therapeutic responses under physiologically relevant contexts.
"Understanding how metabolic conditions within tumors influence immune-cell behavior is increasingly important in immuno-oncology," said a senior scientific director at Creative Biolabs. "Dr. Delgoffe's work provides an important perspective on how researchers can model these conditions and investigate target discovery and validation." The webinar will cover key topics including how tumor metabolic environments contribute to immune suppression and T cell exhaustion, strategies for modeling TME conditions in preclinical research, the mechanisms underlying T cell exhaustion influenced by nutrient depletion, and how immunometabolism insights can guide therapeutic strategies to enhance cancer immunotherapy.
This webinar is particularly relevant for cancer immunology researchers, pharmaceutical and biotechnology professionals, and R&D teams dedicated to oncology drug discovery. Attendees will have the opportunity to learn from a leading expert and explore practical approaches to improve the translational value of preclinical studies. For more details and registration, visit the official webinar page at https://www.creative-biolabs.com/immuno-oncology/webinar-modeling-t-cell-dysfunction-tumor-microenvironments.htm.
Creative Biolabs is a biotechnology service provider supporting immuno-oncology research and preclinical drug development. Its capabilities include antibody discovery and engineering, tumor microenvironment research, immunological assays, and customized preclinical research solutions for pharmaceutical, biotechnology, and academic organizations.
